The Cooper Companies (NYSE:COO) updated its FY 2021 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $13.200-13.400 for the period, compared to the Thomson Reuters consensus estimate of $13.040. The company issued revenue guidance of $2.86 billion-2.89 billion, compared to the consensus revenue estimate of $2.83 billion.
A number of brokerages recently commented on COO. KeyCorp upped their price target on shares of The Cooper Companies from $429.00 to $444.00 and gave the company an overweight rating in a research note on Wednesday, April 28th. They noted that the move was a valuation call. Piper Sandler increased their target price on shares of The Cooper Companies from $435.00 to $440.00 and gave the stock an overweight rating in a research note on Tuesday, June 1st. Citigroup increased their target price on shares of The Cooper Companies from $355.00 to $378.00 and gave the stock a neutral rating in a research note on Friday, March 5th. Jefferies Financial Group reiterated a buy rating and issued a $450.00 target price on shares of The Cooper Companies in a research note on Monday, May 24th. Finally, Raymond James increased their target price on shares of The Cooper Companies from $375.00 to $415.00 and gave the stock an outperform rating in a research note on Friday, March 5th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The Cooper Companies presently has an average rating of Buy and a consensus target price of $388.38.
Shares of NYSE:COO traded up $1.71 during trading on Thursday, reaching $374.12. The company had a trading volume of 275,726 shares, compared to its average volume of 280,549. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 0.75. The Cooper Companies has a 12 month low of $268.92 and a 12 month high of $415.96. The company has a fifty day moving average price of $393.29. The stock has a market cap of $18.42 billion, a PE ratio of 7.89, a P/E/G ratio of 2.81 and a beta of 0.82.
In related news, SVP Agostino Ricupati sold 2,643 shares of the stock in a transaction on Thursday, April 15th. The shares were sold at an average price of $397.92, for a total transaction of $1,051,702.56. Following the transaction, the senior vice president now owns 2,709 shares of the company’s stock, valued at approximately $1,077,965.28. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.70% of the stock is currently owned by company insiders.
The Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Read More: What is operating income?
Receive News & Ratings for The Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.